Navigation Links
Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
Date:1/30/2013

WATERTOWN, Mass., Jan. 30, 2013 /PRNewswire-iReach/ -- BlueMetal Architects, a leading design and technology services firm, today announced that it has appointed former Microsoft Health Solutions Group Director and Health IT entrepreneur, David Le Penske , to be Vice President of Health & Life Sciences.  Mr. Le Penske will be based in BlueMetal's Boston office and will be responsible for leading the Health and Life Sciences growth strategy for the company across BlueMetal's Boston, New York and Chicago locations.

Mr. Le Penske has a long track record of entrepreneurial and corporate leadership experience across sales, marketing, and development of strategic partnership alliances, including the last 10 years specifically in the Health IT industry. Most recently, he served as Vice President of Business Development and Sales for Get Real Health, a leading Maryland-based consumer health software company.  Prior to that, Mr. Le Penske served as Director, Microsoft Health Solutions Group where he was responsible for leading Microsoft's enterprise Amalga and consumer HealthVault sales and business development initiatives across Canada's government, business and consumer markets – including the MyHealth Alberta citizen portal project. Mr. Le Penske also managed the strategic partner relationship with TELUS concerning TELUS health space, powered by Microsoft HealthVault.

In 2003, Mr. Le Penske founded AccelMD, a leading supplier of healthcare information and navigation services and wellness solutions, to improve health and enhance the quality of life for individuals, groups and organizations.  As co-founder and CEO, he led AccelMD's business growth strategy and was responsible for driving revenue and expanding service solution offerings including a distribution agreement with Manulife Financial Corporation's Group and Individual Benefits divisions. He and his partners sold the company to WorldCare of Boston, MA in 2012.

"In my view, there has simply never been a greater time in the history of medicine where technology can make such a profoundly positive impact," said Mr. Le Penske .  "Similar to financial services a decade ago, healthcare data and insights should be securely and readily accessible to approved users on any device that connects to the internet, and modern applications will play a pivotal role in making our health easy to understand, self-serve and more accountably managed."

"David has a tremendous vision for the future of Health Care, where heterogeneous data can be combined into a highly secure cloud-based "big data" asset that can be connected to modernized workflows and applications to facilitate collaboration across the continuum of care," said Todd Bremner , CEO and Chief Architect of BlueMetal Architects. "BlueMetal's design and delivery capabilities will speed the impact of David's vision to enable research-based medicine to become a more connected and personalized evidence-based care."

In the coming year Mr. Le Penske will work with BlueMetal's practice teams and General Managers in Boston, New York, and Chicago to drive strategy and execution focused on winning key projects to advance the state of the art in Health and Life Sciences by increasing client, strategic partner and project revenue growth and market share across the Health and Life Sciences vertical.



Media Contact: Sadalit Van Buren BlueMetal Architects, (617) 431-5752, svanburen@bluemetal.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE BlueMetal Architects
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
2. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
3. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
4. The American Society for Microbiology honors David Tobin
5. Environmental activist David Suzuki is fifth recipient of CWRU’s Inamori Ethics Prize
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
8. NASA Goddard scientist receives Presidential Early Career Award
9. ONR-funded young innovators recognized by President
10. President Obama honors MU researcher with National Medal of Science
11. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... 2016 --> ... research report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, ... Expression, Voice Recognition and Others), Services, Application Areas, ... 2020", published by MarketsandMarkets, the global Emotion Detection ... 22.65 Billion by 2020, at a CAGR of ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 4, 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today provided an update on ... Northern District of Texas and ... Inter Partes Re-examination ("IPR") proceedings that VTech ... IPR was initiated on only certain claims of two ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
Breaking Biology Technology: